Drug intelligence / Profile preview

FR236913

Development stage
Unknown
Modality
Small Molecules
01

Overview

FR236913 is an experimental small molecule compound belonging to the class of organic compounds known as n-alkylindoles. It has been identified as an inhibitor of adenosine deaminase, a key enzyme involved in purine metabolism and adenosine homeostasis. The compound's chemical formula is C24H26N6O3 and it has a molecular weight of approximately 446.5 g/mol. While its primary mechanism is inhibition of adenosine deaminase, there are no approved indications or associated clinical trials reported for this agent to date[1][2][3][4]. It has been studied in silico for potential activity against viral proteases, including SARS-CoV-2 main protease[7].

Other names
1-[(1R)-3-(6-{[(benzylamino)carbonyl]amino}-1H-indol-1-yl)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamideFR9FR-9FR 9
02

Targets

ADA (Adenosine deaminase)

Beyond the preview

Go deeper on FR236913.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FR236913.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call